My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Clin Infect Dis. 2002 Oct 1;35(7):880-2. Epub 2002 Sep 11.

    Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy.

    Aaron L, Lidove O, Yousry C, Roudiere L, Dupont B, Viard JP.

    Service des Maladies Infectieuses et Tropicales, Hôpital Necker Enfants-Malades, 75743 Paris Cedex 15, France. LAAARON@wanadoo.fr

    Abstract

    We report the case histories of 7 human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART) who had a diagnosis of Castleman disease. All 6 patients who were treated responded to chemotherapy; immune reconstitution was observed in 5 patients, but it did not prevent relapse of Castleman disease. However, the mean duration of survival observed in this series (48 months) was most probably due to immune reconstitution resulting from receipt of HAART, which reduced the mortality associated with HIV disease.

    PMID: 12228826 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk